Los fármacos de acción prolongada podrían revolucionar el tratamiento de VIHnews2024-04-21T07:02:00+00:00April 21st, 2024|The New York Times|
Addiction Risk Scores Won’t Solve the Opioid Crisisnews2024-04-20T11:00:44+00:00April 20th, 2024|The New York Times|
How Ozempic Is Transforming a Small Danish Townnews2024-04-20T04:01:50+00:00April 20th, 2024|The New York Times|
Inside Novo Nordisk, the Company Behind Ozempic and Wegovynews2024-04-20T04:01:23+00:00April 20th, 2024|The New York Times|
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatmentnews2024-04-17T22:46:45+00:00April 17th, 2024|The New York Times|
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reportsnews2024-04-17T18:33:32+00:00April 17th, 2024|The New York Times|
Why Is There a Tick Vaccine For Dogs and Not Humans?news2024-04-16T09:02:07+00:00April 16th, 2024|The New York Times|
David Egilman, Doctor Who Took On Drug Companies, Dies at 71news2024-04-15T21:59:12+00:00April 15th, 2024|The New York Times|
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugsnews2024-04-15T19:47:14+00:00April 15th, 2024|The New York Times|
